Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Karnofsky performance status revisited: reliability, validity, and guidelines.

C C Schag, R L Heinrich, P A Ganz

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |March 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial.

    Psycho-oncology·2015
    Same author

    The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.

    Brain imaging and behavior·2013
    Same journal

    Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    Same journal

    Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    Same journal

    Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    Same journal

    Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    Same journal

    Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    Same journal

    Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    See all related articles

    The Karnofsky Performance Status (KPS) scale shows good reliability and validity in cancer patients. New guidelines improve KPS accuracy for clinical use and research.

    Area of Science:

    • Oncology
    • Clinical Assessment
    • Psychometrics

    Background:

    • Limited research exists on the Karnofsky Performance Status (KPS) scale's reliability and validity.
    • Empirical data-driven guidelines for KPS scale use are lacking.

    Purpose of the Study:

    • To evaluate the interrater reliability and construct validity of the KPS scale.
    • To identify key variables for predicting KPS scores and develop standardized assessment guidelines.

    Main Methods:

    • 293 cancer patients completed a physical and psychosocial difficulties questionnaire.
    • Physicians rated patients using the KPS scale; interrater reliability was assessed on 75 patients.
    • Multiple regression analysis identified predictors of KPS scores.

    Related Experiment Videos

    Main Results:

    • The KPS scale demonstrated good reliability and validity.
    • Seven behaviorally based variables (weight changes, energy, mobility, daily activities) were identified as predictors.
    • Physician judgment errors in KPS assessment were identified.

    Conclusions:

    • The KPS scale is a reliable and valid measure for cancer patients.
    • A proposed interview approach with behaviorally based guidelines can enhance KPS rating accuracy.
    • Standardized KPS assessment has implications for patient care and research stratification.